{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:56:39Z","timestamp":1781679399935,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024 M751825"],"award-info":[{"award-number":["2024 M751825"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cellsig.2025.112124","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:04:26Z","timestamp":1757502266000},"page":"112124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["BCAR3 confers resistance to cisplatin in head and neck squamous cell carcinoma by sustaining TGF-\u03b2\/SMAD signaling"],"prefix":"10.1016","volume":"136","author":[{"given":"Yaning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.20.02072","article-title":"ARTSCAN III: a randomized phase III study comparing Chemoradiotherapy with cisplatin versus Cetuximab in patients with Locoregionally advanced head and neck squamous cell Cancer","volume":"39","author":"Gebre-Medhin","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12032-023-02237-w","article-title":"Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy","volume":"41","author":"Fu","year":"2023","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","volume":"7","author":"Cohen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cellsig.2025.112124_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.actbio.2016.09.045","article-title":"Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles","volume":"47","author":"Nascimento","year":"2017","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112124_bb0025","first-page":"1295","article-title":"Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells","volume":"10","author":"Lan","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"47","key":"10.1016\/j.cellsig.2025.112124_bb0030","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.cellsig.2025.112124_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158199","article-title":"Targeting DNA damage response and repair to enhance therapeutic index in cisplatin-based Cancer treatment","volume":"22","author":"Kiss","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112124_bb0040","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","article-title":"TGF-\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma","volume":"160","author":"Oshimori","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2025.112124_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241274337","article-title":"Tumor-associated macrophage-derived TGF-\u03b21 activates GLI2 via the Smad2\/3 signaling pathway to affect cisplatin resistance in lung adenocarcinoma","volume":"23","author":"Lan","year":"2024","journal-title":"Technol. Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.32604\/or.2023.031404","article-title":"TGF-\u03b2-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer","volume":"32","author":"Wu","year":"2023","journal-title":"Oncol. Res."},{"issue":"17","key":"10.1016\/j.cellsig.2025.112124_bb0055","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.7150\/jca.58049","article-title":"ADNP prompts the cisplatin-resistance of bladder cancer via TGF-\u03b2-mediated epithelial-mesenchymal transition (EMT) pathway","volume":"12","author":"Xie","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.32604\/or.2023.030190","article-title":"Cisplatin-induced activation of TGF-\u03b2 signaling contributes to drug resistance","volume":"32","author":"Imatsuji","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.cellsig.2025.112124_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112235","article-title":"TGF \u03b21 promotes the polarization of M2-type macrophages and activates PI3K\/mTOR signaling pathway by inhibiting ISG20 to sensitize ovarian cancer to cisplatin","volume":"134","author":"Wu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.cellsig.2025.112124_bb0070","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1158\/0008-5472.CAN-08-4623","article-title":"Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K\/Akt pathway","volume":"69","author":"Bian","year":"2009","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.cellsig.2025.112124_bb0075","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1128\/MCB.00214-12","article-title":"Protein tyrosine phosphatase \u03b1 phosphotyrosyl-789 binds BCAR3 to position Cas for activation at integrin-mediated focal adhesions","volume":"32","author":"Sun","year":"2012","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112124_bb0080","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/emboj\/17.10.2799","article-title":"Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells","volume":"17","author":"van Agthoven","year":"1998","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0085","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jmb.2008.12.010","article-title":"Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in anti-oestrogen resistance","volume":"386","author":"Garron","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112124_bb0090","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/nsmb.2152","article-title":"NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling","volume":"18","author":"Mace","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ncb3464","article-title":"A ROR1-HER3-lncRNA signalling axis modulates the hippo-YAP pathway to regulate bone metastasis","volume":"19","author":"Li","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41420-021-00714-7","article-title":"BCAR3 promotes head and neck cancer growth and is associated with poor prognosis","volume":"7","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12964-025-02077-3","article-title":"TNFAIP2 promotes NF-\u03baB signaling mediate lymph node metastasis of oral squamous cell carcinoma by protecting IKK\u03b2 from ubiquitin proteasome degradation","volume":"23","author":"Xu","year":"2025","journal-title":"Cell Commun. Signal. CCS"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0110","first-page":"190","article-title":"TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1\/NRF2 signaling","volume":"42","author":"Xu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1677\/ERC-06-0027","article-title":"Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway","volume":"14","author":"Chen","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2025.112124_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejca.2021.06.039","article-title":"First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck: efficacy and safety results of the randomised, phase III CHANGE-2 trial","volume":"156","author":"Guo","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13402-017-0365-1","article-title":"Role of \u03b2-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma","volume":"41","author":"Roy","year":"2018","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","article-title":"Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition","volume":"21","author":"Heldin","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112124_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16091674","article-title":"Deciphering the role of BCAR3 in Cancer progression: gene regulation, signal transduction, and therapeutic implications","volume":"16","author":"Moon","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12967-018-1728-8","article-title":"Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma","volume":"16","author":"Zhang","year":"2018","journal-title":"J. Transl. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112124_bb0150","first-page":"4768","article-title":"Breast Cancer antiestrogen resistance 3 (BCAR3) promotes tumor growth and progression in triple-negative breast cancer","volume":"11","author":"Arras","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112124_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/jfb13040158","article-title":"Curcumin-encapsulated Nanomicelles improve cellular uptake and cytotoxicity in cisplatin-resistant human Oral Cancer cells","volume":"13","author":"Kumbar","year":"2022","journal-title":"J Funct Biomater"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112124_bb0160","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/1078-0432.CCR-20-3322","article-title":"Targeting germline- and tumor-associated nucleotide excision repair defects in Cancer","volume":"27","author":"Topka","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112124_bb0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s13402-016-0291-7","article-title":"The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells","volume":"39","author":"Chen","year":"2016","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0170","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7150\/ijbs.76223","article-title":"Molecular mechanisms of mitochondrial quality control in ischemic cardiomyopathy","volume":"19","author":"Chang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112124_bb0175","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1007\/s00204-023-03599-w","article-title":"Involvement of mitochondrial dynamics and mitophagy in diabetic endothelial dysfunction and cardiac microvascular injury","volume":"97","author":"Zhang","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112124_bb0180","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","article-title":"Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction","volume":"27","author":"Pang","year":"2024","journal-title":"Angiogenesis"},{"issue":"47","key":"10.1016\/j.cellsig.2025.112124_bb0185","article-title":"Gastric cancer actively remodels mechanical microenvironment to promote chemotherapy resistance Via MSCs-mediated mitochondrial transfer","volume":"vol. 11","author":"He","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0190","first-page":"65","article-title":"METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy","volume":"42","author":"Sun","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"2","key":"10.1016\/j.cellsig.2025.112124_bb0195","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41556-022-00843-w","article-title":"Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance","volume":"24","author":"Romani","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.112124_bb0200","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.7150\/ijbs.95853","article-title":"Nuclear receptor subfamily 4 group a member 1 promotes myocardial ischemia\/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","article-title":"New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation","volume":"29","author":"Li","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/jtim-2022-0023","article-title":"Revising the hemodynamic criteria for pulmonary hypertension: a perspective from China","volume":"11","author":"Xiong","year":"2023","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.cellsig.2025.112124_bb0215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22187","article-title":"Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells","volume":"6","author":"Dong","year":"2017","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.cellsig.2025.112124_bb0220","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1158\/2767-9764.CRC-23-0144","article-title":"Mitochondria transfer from mesenchymal stem cells confers Chemoresistance to glioblastoma stem cells through metabolic rewiring","volume":"3","author":"Nakhle","year":"2023","journal-title":"Cancer Res. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2025.112124_bb0225","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/ptr.8177","article-title":"Quercetin inhibits necroptosis in cardiomyocytes after ischemia-reperfusion via DNA-PKcs-SIRT5-orchestrated mitochondrial quality control","volume":"38","author":"Chang","year":"2024","journal-title":"Phytother. Res. PTR"},{"key":"10.1016\/j.cellsig.2025.112124_bb0230","article-title":"Ginsenoside Rb1 ameliorates heart failure through DUSP-1-TMBIM-6-mediated mitochondrial quality control and gut flora interactions","volume":"132","author":"Pu","year":"2024","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.cellsig.2025.112124_bb0235","article-title":"Zishenhuoxue decoction-induced myocardial protection against ischemic injury through TMBIM6-VDAC1-mediated regulation of calcium homeostasis and mitochondrial quality surveillance","volume":"132","author":"Chang","year":"2024","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.cellsig.2025.112124_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117371","article-title":"Zishen Tongyang Huoxue decoction (TYHX) alleviates sinoatrial node cell ischemia\/reperfusion injury by directing mitochondrial quality control via the VDAC1-\u03b2-tubulin signaling axis","volume":"320","author":"Chang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cellsig.2025.112124_bb0245","article-title":"\u00df-tubulin contributes to Tongyang Huoxue decoction-induced protection against hypoxia\/reoxygenation-induced injury of sinoatrial node cells through SIRT1-mediated regulation of mitochondrial quality surveillance","volume":"108","author":"Chang","year":"2023","journal-title":"Phytomed. Int. J. Phytother. Phytopharmacol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112124_bb0250","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/cas.16242","article-title":"FoxG1\/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma","volume":"115","author":"Pan","year":"2024","journal-title":"Cancer Sci."},{"issue":"13","key":"10.1016\/j.cellsig.2025.112124_bb0255","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.7150\/ijbs.96748","article-title":"Exploring the mechanism of Ferroptosis induction by Sappanone a in Cancer: insights into the mitochondrial dysfunction mediated by NRF2\/xCT\/GPX4 Axis","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2025.112124_bb0260","first-page":"1","article-title":"TGFB signaling induces mitophagy via PLSCR3-mediated cardiolipin externalization in conjunction with a BNIP3L\/NIX-, BNIP3-, and FUNDC1-dependent mechanism","author":"Yan","year":"2025","journal-title":"Autophagy"},{"issue":"20","key":"10.1016\/j.cellsig.2025.112124_bb0265","doi-asserted-by":"crossref","first-page":"20353","DOI":"10.1002\/cam4.6621","article-title":"Efficacy and safety of abemaciclib alone and with PI3K\/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: a randomized controlled trial","volume":"12","author":"Chiorean","year":"2023","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112124_bb0270","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12885-023-11153-1","article-title":"A phase Ib\/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer","volume":"23","author":"Nadal","year":"2023","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2025.112124_bb0275","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1470-2045(22)00446-6","article-title":"Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial","volume":"23","author":"Yamazaki","year":"2022","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112124_bb0280","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10637-021-01207-1","article-title":"Radiosensitizing effect of galunisertib, a TGF-\u00df receptor I inhibitor, on head and neck squamous cell carcinoma in vitro","volume":"40","author":"Jank","year":"2022","journal-title":"Investig. New Drugs"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112124_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004029","article-title":"CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype","volume":"10","author":"Li","year":"2022","journal-title":"J. Immunother. Cancer"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500539X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500539X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:35:59Z","timestamp":1781678159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682500539X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S089865682500539X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112124","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCAR3 confers resistance to cisplatin in head and neck squamous cell carcinoma by sustaining TGF-\u03b2\/SMAD signaling","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112124"}}